Back to search

Article

An IPI based immune prognostic model for diffuse large B-cell lymphoma

2021-03-04

Abstract excerpt

<h4>Background</h4> International Prognostic Index (IPI) was widely used to better discriminate prognosis of patients with diffuse large B-cell lymphoma (DLBCL). However, there is a significant need to identify novel valuable biomarkers in the context of targeted therapies, such as immune checkpoint blockade (ICB) therapy. <h4>Methods</h4> Gene expression data and clinical information of DLBCL were obtained from...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d06cc889-49b0-5934-96d8-709c681533ae
DOI
10.1101/2021.03.03.433839
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An IPI based immune prognostic model for diffuse large B-cell lymphomaDOI 10.1101/2021.03.03.433839
Select a neighboring publication to make it the new centre.